Skip to content

Clinical trials

Phase 1/2 Amyotrophic Lateral Sclerosis trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Amyotrophic Lateral Sclerosis Phase: Phase 1/2 Status: Unknown status Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20163
20181
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amylyx Pharmaceuticals Inc.1
Collaborative Medicinal Development Pty Limited1
Hanyang University Seoul Hospital1
Phoenix Neurological Associates, LTD1
Polski Bank Komorek Macierzystych JSC (PBKM)1
Stem Cells Arabia1
University of Sao Paulo General Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Amyotrophic Lateral Sclerosis7
Motor Neuron Disease2
Bulbar Palsy, Progressive1
Muscular Atrophy, Spinal1
Nervous System Diseases1
Neurodegenerative Diseases1
Neuromuscular Diseases1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.